期刊文献+

Real-time Quantitative PCR Analysis of Vascular Endothelial Growth Factor Receptor-2(VEGFR-2) Expression at Zebrafish Different Developmental Stages 被引量:2

斑马鱼不同发育时期血管内皮生长因子受体2(VEGFR-2)基因表达的实时定量PCR分析(英文)
在线阅读 下载PDF
导出
摘要 [Objective]To investigate the expression of zebrafish vascular endothelial growth factor-2(VEGFR-2) at different developmental stages.[Method]Total RNAs were extracted from 12,24,48,72 and 96 hpf stage zebrafish embryos and larvae.Real-time quantitative RT-PCR was performed to examine the expression of VEGFR-2.The data were analyzed by 2^-△△Ct method.[Result]The expression level of VEGFR-2 gene increased gradually from 12 to 72 hpf,and subsequently decreased at 96 hpf.The expression level was lowest at 12 hpf,highest at 72 hpf,and had significant differences when compared with that of other developmental stages.[Conclusion]The expression level of VEGFR-2 increases gradually before blood vessel maturation and decreases as blood vessels mature. [目的]探讨血管内皮生长因子受体2(VEGFR-2)基因在斑马鱼不同发育时期的表达。[方法]采用Trizol法分别提取12、24、48、72和96h斑马鱼胚胎和仔鱼总RNA;再使用MMLV反转录酶将其反转录为cDNA;合成的cDNA用实时定量RT-PCR方法检测VEGFR-2基因的表达。实时定量RT-PCR扩增反应结束后,利用熔解曲线对扩增产物进行特异性分析。采用2-△△Ct法进行数据分析。[结果]VEGFR-2基因表达量在12~72h呈上升趋势,在96h时有所下降。12h相对表达量最低,与其他发育期差异极显著(P<0.01),72h相对表达量最高,与12、24和96h差异极显著(P<0.01),与48h差异显著(P<0.05)。[结论]斑马鱼血管发育至72h达成熟阶段,血管发育成熟前,VEGFR-2基因表达水平逐步增长;血管发育成熟后,VEGFR-2基因表达水平下降。
出处 《Agricultural Science & Technology》 CAS 2010年第4期118-120,共3页 农业科学与技术(英文版)
基金 Supported by National Natural Science Foundation of Shandong Province (No. SY2008C179)~~
关键词 ZEBRAFISH Real-time quantitative PCR VEGFR-2 斑马鱼 实时定量 血管内皮生长因子受体2
  • 相关文献

参考文献17

  • 1STAINIERD YR,FISHMAN MC.The zebrafish as a model to study cardio-vascular development[J].Trends Cardiovasc Med,1994,4:207.
  • 2DODD A,CURTIS PM,WILLIAMS LC,et al.Zebrafish:bridging the gap between development and disease[J].Hum Mol Genet,2000,9:2443.
  • 3DE JONG JL,ZON LI.Use of the zebrafish system to study primitive and definitive hematopoiesis[J].Annu Rev Genet,2005,39:481-501.
  • 4TANAKA T,OKA T,SHIMADA Y,et al.Pharmacogenomics of cardiovascular pharmacology:pharmacogenomic network of cardiovascular disease models[J].J Pharmacol Sci,2008,107(1):8-14.
  • 5SHALABY F,ROSSANT J,YAMAGUCHI TP,et al.Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice[J].Nature,1995,376(6535):62-66.
  • 6ROSKOSKI R JR.VEGF receptor protein-tyrosine kinases:structure and regulation[J].Biochem Biophys Res Commun,2008,375:287-291.
  • 7WESTERFIELD M.The zebrafish book:a guide for the laboratory use of zebrafish (Danio rerio)[M].Eugene:University of Oregon Press,1995:31-46.
  • 8KIMMEL CB,BALLARD WW,KIMMEL SR,et al.Stages of embryonic development of the zebrafish[J].Dev Dyn,1995,203:253-310.
  • 9LIVAK KJ,SCHMITTGEN TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method[J].Methods,2001,25:402-408.
  • 10THOMPSON MA,RANSOM DG,PRATT SJ,et al.Thecloche and spadetail genes differentially affect hematopoiesis and vasculogenesis[J].Dev Biol,1998,197(2):248-269.

同被引文献42

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部